noevir holdings co.,ltd. (4928) Stock Price

Noevir Holdings is a holding company group engaged primarily in the manufacturing and sale of cosmetics, toiletries, pharmaceuticals, and food products, as well as the purchase and resale of cosmetic accessories. The group operates multiple subsidiaries both domestically and internationally. Its core business is cosmetics, offering a wide range of products including face-to-face counseling sales, drugstore products, and OEM supply.

The company's primary customers are individual consumers. Sales channels include face-to-face sales through sales agents, retail stores and drugstores through wholesalers, medical institutions, and a direct sales network. Revenue is primarily generated through product sales via these channels. While domestic sales represent a significant portion, overseas subsidiaries in the United States, Canada, Taiwan, China, and other markets also contribute to revenue.

The business is divided into three main segments: "Cosmetics Business," "Pharmaceuticals and Food Business," and "Other Business." The Cosmetics Business comprises counseling cosmetics, self-service cosmetics, and OEM lines. The Pharmaceuticals and Food Business handles over-the-counter drugs, quasi-drugs, and nutritional supplements. The Other Business includes diversified operations such as apparel, air transportation, and pilot training.

The company has established "sustainable management across group businesses to achieve disciplined growth" as its medium- to long-term basic policy. It aims to maximize corporate value using revenue, operating profit, and return on equity (ROE) as key performance indicators. While economic recovery is expected, the company faces downside risks to consumer spending from rising prices. Therefore, it prioritizes stable profit generation while strengthening its business structure to improve profitability. Although specific numerical targets have not been disclosed at this time, the company is committed to rigorous management using these indicators.

The company has identified brand value enhancement and diversification of research and development, production, and logistics as priority investment areas, with cosmetics as its core differentiator. Specifically, it is strengthening face-to-face counseling sales and optimizing product lineups by channel through expanded self-service cosmetics for drugstores and increased OEM supply. The company also aims to promote diversity in talent and organization, differentiating itself through product development and marketing tailored to regional and customer segments.

The company is strengthening overseas expansion while maintaining its domestic foundation in new market development and business growth. It already has subsidiaries in the United States, Canada, Taiwan, and China. Through these bases, it plans to expand overseas sales by increasing sales volume, introducing products suited to local needs, and strengthening sales networks through wholesalers and medical institutions. Additionally, the company is optimizing direct sales and wholesale routes and expanding direct sales channels to meet diverse latent consumer demand.

The company prioritizes research and development investment and strengthening production and logistics capabilities as part of its technology innovation efforts. Specifically, it is accelerating product development through new formulations and enhanced safety testing, ensuring stable supply through multi-site production systems, and building mechanisms to incorporate customer counseling data into product design. Through these initiatives, the company aims to respond flexibly to market changes and improve long-term competitiveness.